Home | Video pages | E-seminar | SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?

SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?

EuReCa-M Working Group

SGLT2 inhibitors and haemoglobin

Speaker
Lucia Del Vecchio, Italy

Panellists
Olga Balafa, Greece
José Manuel Valdivielso, Spain

Moderator
Beatriz Fernandez-Fernandez, Spain

Tuesday, September 24, 2024, at 5:00 PM (CEST)